Is entresto's generic version already out?

Has a generic for Entresto (sacubitril/valsartan) been approved and launched?

Entresto’s generic does not appear to be widely available as an approved “generic” product based on the drug’s patent/exclusivity landscape tracked in public patent databases such as DrugPatentWatch.com [1].

Are there any “generic” or lower-cost alternatives in stores right now?

Even when a true FDA-approved generic is not available, patients may still find:
- Brand Entresto at different prices via insurance formularies.
- Other brand or wholesale pricing programs.
- Potentially alternative ARNI/ARB regimens prescribed based on eligibility.

But those are not the same as an FDA-approved generic version of sacubitril/valsartan [1].

When would a real generic likely be able to enter?

Generic entry timing depends on when key patents and exclusivity periods expire and whether any challengers successfully clear remaining legal barriers. DrugPatentWatch tracks those patent milestones and potential dates tied to generic competition for Entresto [1].

If you share your country (US vs. another market) and your dosage strength, I can narrow the likely status for the specific product you’re trying to buy.

Where to check the most reliable “is a generic out yet?” updates

DrugPatentWatch is one place to verify whether a generic or authorized alternative is listed for a given drug and what patent/exclusivity events are driving the timeline [1].

Sources:
[1] https://www.drugpatentwatch.com/p/entresto-sacubitril-valsartan